PHOENIX, Oct. 5, 2016 /PRNewswire/ -- Axolotl Biologix, Inc., a biologics company that focuses on human tissue research and technology to enhance regenerative medicine, announced today that it will be attending the NCAI 73rd Annual Conference as an exhibitor. The conference will be held October 9-14 at the Phoenix Convention Center in Phoenix, Arizona.
About Axolotl Biologix, Inc.
Axolotl Biologix, Inc. is a biologics company that develops and manufactures human tissue regenerative medicine products for orthopedic, wound care, podiatric, and cosmetic conditions. The Company's lead product is its AxoBioFluid™, which is an amniotic allograft cryopreserved liquid that advances soft tissue repair, replacement, and reconstruction. The Company's vision is to be an innovative leader in regenerative medicine through research, technology, and clinical application.
For more information, please visit Axolotl Biologix' website at www.axobio.com